Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:48 pm Unchanged | 13G | IKENA ONCOLOGY INC IKNA | Omega Fund VI L.P. | 2,249,123 4.7% | 0 (Unchanged) | View |
| 2024-02-14 4:43 pm Sale | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Omega Fund VI L.P. | 0 0% | -2,415,050 (Position Closed) | View |
| 2024-02-14 4:43 pm Purchase | 13G | LEXEO THERAPEUTICS INC LXEO | Omega Fund VI L.P. | 2,157,623 8.1% | 2,157,623 (New Position) | View |
| 2023-02-13 4:46 pm Unchanged | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Omega Fund VI L.P. | 2,415,050 5.2% | 0 (Unchanged) | View |
| 2022-02-14 3:21 pm Purchase | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Omega Fund VI L.P. | 2,415,050 8.2% | 2,415,050 (New Position) | View |
| 2022-02-14 2:57 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | Omega Fund VI L.P. | 2,249,123 6.3% | 2,249,123 (New Position) | View |
| 2022-02-14 2:09 pm Purchase | 13G | IMAGO BIOSCIENCES INC IMGO | Omega Fund VI L.P. | 3,018,737 9% | 3,018,737 (New Position) | View |
| 2021-02-12 2:13 pm Purchase | 13G | CHECKMATE PHARMACEUTICALS, INC CMPI | Omega Fund VI L.P. | 1,335,050 6.2% | 1,335,050 (New Position) | View |
| 2021-02-12 1:46 pm Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | Omega Fund VI L.P. | 2,161,023 9.3% | 2,161,023 (New Position) | View |